Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Summary

RATIONALE: Gefitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving Gefitinib before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This phase II trial is studying how well gefitinib works in treating patients with stage IIIA non-small cell lung cancer.

Timeline

Start

2006-11

Primary completion

2010-11

Completion

—

Drugs

Indications